Denton, CP;
Campochiaro, C;
Bruni, C;
Distler, O;
Iagnocco, A;
Matucci Cerinic, M;
(2020)
COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic.
Journal of Scleroderma and Related Disorders
10.1177/2397198320963393.
(In press).
Preview |
Text
2397198320963393.pdf - Published Version Download (578kB) | Preview |
Abstract
COVID-19, caused by infection of the novel coronavirus SARS-CoV-2, has caused a pandemic of enormous impact that has challenged healthcare and political system throughout the world. This new health emergency has occurred on top of the usual burden of diseases, including systemic sclerosis, and has led to many unanticipated consequences. An early consequence of the pandemic was postponement of the Sixth Systemic Sclerosis World Congress that was recently completed as a successful virtual congress with more than 1000 delegates. In this article, we summarise the relevance and impact of COVID-19 from the perspective of systemic sclerosis. Shared concepts of pathogenesis are considered, and the relevant literature emerging about COVID-19 and systemic sclerosis summarised. The specific impact of this pandemic on delivery of optimal scleroderma care is considered, together with the broader effect on rheumatic and musculoskeletal diseases and the activities of European League Against Rheumatism. As the World continues to struggle against this new infectious disease, it is notable that expertise and growing understanding of systemic sclerosis has been able to help tackle COVID-19. Moreover, the essential adjustments to deliver clinical care and establishment of new ways of working due to the pandemic have offered potential avenues for future improvement in systemic sclerosis care.
| Type: | Article |
|---|---|
| Title: | COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1177/2397198320963393 |
| Publisher version: | https://doi.org/10.1177/2397198320963393 |
| Language: | English |
| Additional information: | This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| Keywords: | COVID-19, lung fibrosis, pathogenesis, EULAR, scleroderma |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10113417 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
